In breast cancer, TDP-43 modulates the majority of splicing events via the serine/arginine-rich splicing factor 3 (SRSF3), thereby regulating the progression of triple-negative breast cancer (Ke et al. 2018). Here, TARDBP is linked to triple-negative breast carcinoma.